Talking points

emphasises the value of FAIR to the clinical space, including making data machine-readable to support AI, innovating in clinical trial design, and enabling the transfer of data between sponsors, CROs, and regulatory agencies. FAIR4Clin was co-authored by the Pistoia Alliance and other experts in the field, including AstraZeneca, Bayer, Roche, Genentech, Galapagos, The Hyve, Elixir, The University of Manchester and Oxford University.

“We’ve had huge interest in the FAIR project since its launch, even more so after the Covid-19 pandemic reiterated the importance of being able to reuse and share clinical trial and healthcare data to accelerate drug development timelines. We are now calling on even more organisations to get involved in the next phase of the project, which will examine the business value of FAIR and develop further tangible resources, enabling best practices across industries, increasing more interoperability and effective collaborations,” commented Giovanni Nisato, PhD, project lead at the Pistoia Alliance.

Check out the latest news and insights in the world of medical devices at Med Tech Innovation: www.med-technews.com.

Bachem Partners With Simplynano Project To Inspire Young People With Nanotechnology

Bachem, a Swiss pharmaceutical company, has partnered with the SimplyNano project, educational experiment kits published by the non-profit foundation SimplyScience. This project aims to get young people excited about science and technology with the help of nano experiments.

The project involves the “SimplyNano 2”, which is a comprehensive nano-experimental kit for schools. Published by the SimplyScience Foundation and developed by Innovationsgesellschaft (a St. Gallen-based start-up), these kits are available free of charge for some secondary schools in northwestern Switzerland. By 2025, the SimplyNano 2 experiment kits should be available throughout Switzerland.

Nanotechnology deals with substances and materials of less than 100 nanometres, otherwise known as nanoscale. Nanotechnology often manipulates individual atoms and molecules to produce unique properties, making them suitable for a variety of applications.

Bachem focuses on promoting young talent, which is why they are allowing their headquarters training centre to be used by SimplyNano. This helps SimplyNano to achieve its goal of educating young people and inspiring future nanotechnology scientists.

The SimplyNano project is financed by the Basel-Land and Solothurn lottery funds; the Basel-Stadt Department of Education; and sponsorship from companies, associations, and foundations. The high level of support from the 39 project partners highlights the importance of promoting science and technology in schools and fostering young talent.

Be Sure To Listen To

The latest episode of The MedTalk Podcast features a guest speaker from the Med-Tech Innovation Expo.